Comparison of a New Masterful Preparation to Kligman's Trio in the Treatment of Melasma
NCT ID: NCT05119413
Last Updated: 2023-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
40 participants
INTERVENTIONAL
2021-11-30
2022-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Melasma With Stabilized Kligman Preparation Associated or Not With Pulsed Dye Laser
NCT00863278
Anti-pigmenting Effect of a Routine of Facial Products in Subjects With Melasma
NCT06516224
Comparison Of Efficacy Of Combination Of TAM Formula Vs Kligman Formula For Melasma.
NCT06013540
Comparative Study of Dual Yellow Laser Versus Stabilized Kilnman Preparation in the Treatment of Melasma
NCT01850186
Randomized Study Using SM-030 Gel for Adults With Melasma
NCT06454747
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
New traitement
Thiamidol, retinoid, topical steroid preparation
New trio de Kligman
Once daily application in addition to the same sunscreen
Kligman's trio
Application once a day for 12 weeks
Trio Kligman
Once daily application in addition to the same sunscreen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
New trio de Kligman
Once daily application in addition to the same sunscreen
Trio Kligman
Once daily application in addition to the same sunscreen
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Other pigmentary disorder affecting the face
3. Use of systemic or topical steroids or retinoids, use of topical depigmenting agents or depigmenting procedure in the month before the inclusion
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thierry Passeron, PhD
Role: PRINCIPAL_INVESTIGATOR
CHU de Nice, Service de Dermatologie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Nice
Nice, Alpes-maritimes, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-PP-30
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.